We are live on
!
Find out more
SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
33 hedge funds and large institutions have $92.4M invested in scPharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
140% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 5
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
47% more capital invested
Capital invested by funds: $62.9M → $92.4M (+$29.5M)
22% more funds holding
Funds holding: 27 → 33 (+6)
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
0.16% less ownership
Funds ownership: 59.7% → 59.54% (-0.16%)
Holders
33
Holders Change
+6
Holders Change %
+22.22%
% of All Funds
0.73%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
12
Increased
8
Reduced
8
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
+$7.79M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$1.97M |
| 3 |
BFM
Boothbay Fund Management
New York
|
+$837K |
| 4 |
Millennium Management
New York
|
+$254K |
| 5 |
Renaissance Technologies
New York
|
+$209K |
Top Sellers
| 1 |
EP
Eversept Partners
New York
|
-$1.23M |
| 2 |
Squarepoint
New York
|
-$239K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$101K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$88.2K |
| 5 |
AIM
Alambic Investment Management
Belvedere,
California
|
-$68.9K |
